IRIS Accounts Production v25.1.4.42 06410206 Board of Directors 1.1.24 31.12.24 31.12.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh064102062023-12-31064102062024-12-31064102062024-01-012024-12-31064102062022-12-31064102062023-01-012023-12-31064102062023-12-3106410206ns15:EnglandWales2024-01-012024-12-3106410206ns14:PoundSterling2024-01-012024-12-3106410206ns10:Director12024-01-012024-12-3106410206ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3106410206ns10:SmallEntities2024-01-012024-12-3106410206ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3106410206ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3106410206ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3106410206ns10:FullAccounts2024-01-012024-12-3106410206ns10:Director22024-01-012024-12-3106410206ns10:CompanySecretary12024-01-012024-12-3106410206ns10:RegisteredOffice2024-01-012024-12-3106410206ns5:CurrentFinancialInstruments2024-12-3106410206ns5:CurrentFinancialInstruments2023-12-3106410206ns5:Non-currentFinancialInstruments2024-12-3106410206ns5:Non-currentFinancialInstruments2023-12-3106410206ns5:ShareCapital2024-12-3106410206ns5:ShareCapital2023-12-3106410206ns5:RetainedEarningsAccumulatedLosses2024-12-3106410206ns5:RetainedEarningsAccumulatedLosses2023-12-3106410206ns5:PlantMachinery2023-12-3106410206ns5:PlantMachinery2024-01-012024-12-3106410206ns5:PlantMachinery2024-12-3106410206ns5:PlantMachinery2023-12-3106410206ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-12-3106410206ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-01-012024-12-3106410206ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-12-3106410206ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-12-3106410206ns5:CostValuation2023-12-3106410206ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3106410206ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3106410206ns10:Director222023-12-3106410206ns10:Director222022-12-3106410206ns10:Director222024-01-012024-12-3106410206ns10:Director222023-01-012023-12-3106410206ns10:Director222024-12-3106410206ns10:Director222023-12-31064102061ns10:Director12023-12-31064102061ns10:Director12022-12-31064102061ns10:Director12024-01-012024-12-31064102061ns10:Director12023-01-012023-12-31064102061ns10:Director12024-12-31064102061ns10:Director12023-12-31
REGISTERED NUMBER: 06410206 (England and Wales)












Unaudited Financial Statements

for the Year Ended 31 December 2024

for

Northumbrian Medical Supplies Limited

Northumbrian Medical Supplies Limited (Registered number: 06410206)






Contents of the Financial Statements
for the year ended 31 December 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Northumbrian Medical Supplies Limited

Company Information
for the year ended 31 December 2024







DIRECTORS: Mrs J Tomkins
R Tomkins





SECRETARY: Mrs J Tomkins





REGISTERED OFFICE: Normedica House
4 Ruby Park
Brunswick
Newcastle upon Tyne
Tyne and Wear
NE13 7BA





REGISTERED NUMBER: 06410206 (England and Wales)





ACCOUNTANTS: Clayton & Brewill
Chartered Accountants
Cawley House
149-155 Canal Street
Nottingham
Nottinghamshire
NG1 7HR

Northumbrian Medical Supplies Limited (Registered number: 06410206)

Balance Sheet
31 December 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Property, plant and equipment 4 48,318 63,613
Investments 5 3,000 3,000
51,318 66,613

CURRENT ASSETS
Inventories 80,272 61,058
Debtors 6 682,916 720,157
Cash at bank and in hand 7,057 30,935
770,245 812,150
CREDITORS
Amounts falling due within one year 7 171,210 96,246
NET CURRENT ASSETS 599,035 715,904
TOTAL ASSETS LESS CURRENT
LIABILITIES

650,353

782,517

CREDITORS
Amounts falling due after more than
one year

8

(26,763

)

(88,937

)

PROVISIONS FOR LIABILITIES 9 (431,000 ) (431,000 )

ACCRUALS AND DEFERRED INCOME (468 ) (1,100 )
NET ASSETS 192,122 261,480

CAPITAL AND RESERVES
Called up share capital 4 4
Retained earnings 192,118 261,476
SHAREHOLDERS' FUNDS 192,122 261,480

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Northumbrian Medical Supplies Limited (Registered number: 06410206)

Balance Sheet - continued
31 December 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27 September 2025 and were signed on its behalf by:





R Tomkins - Director


Northumbrian Medical Supplies Limited (Registered number: 06410206)

Notes to the Financial Statements
for the year ended 31 December 2024

1. STATUTORY INFORMATION

Northumbrian Medical Supplies Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Stocks
Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Northumbrian Medical Supplies Limited (Registered number: 06410206)

Notes to the Financial Statements - continued
for the year ended 31 December 2024

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2023 - 5 ) .

4. PROPERTY, PLANT AND EQUIPMENT
Plant and
machinery
etc
£   
COST
At 1 January 2024 152,682
Additions 95
At 31 December 2024 152,777
DEPRECIATION
At 1 January 2024 89,069
Charge for year 15,390
At 31 December 2024 104,459
NET BOOK VALUE
At 31 December 2024 48,318
At 31 December 2023 63,613

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and
machinery
etc
£   
COST
At 1 January 2024
and 31 December 2024 97,894
DEPRECIATION
At 1 January 2024 45,123
Charge for year 13,193
At 31 December 2024 58,316
NET BOOK VALUE
At 31 December 2024 39,578
At 31 December 2023 52,771

5. FIXED ASSET INVESTMENTS
Other
investments
£   
COST OR VALUATION
At 1 January 2024
and 31 December 2024 3,000
NET BOOK VALUE
At 31 December 2024 3,000
At 31 December 2023 3,000

Northumbrian Medical Supplies Limited (Registered number: 06410206)

Notes to the Financial Statements - continued
for the year ended 31 December 2024

5. FIXED ASSET INVESTMENTS - continued

Cost or valuation at 31 December 2024 is represented by:

Other
investments
£   
Valuation in 2021 27,826
Valuation in 2022 (428 )
Valuation in 2023 (24,398 )
3,000

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 47,333 42,279
Amounts owed by group undertakings 505,761 495,896
Other debtors 129,822 181,982
682,916 720,157

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 5,556 5,556
Hire purchase contracts 56,618 12,296
Trade creditors 64,873 42,762
Taxation and social security 38,492 34,469
Other creditors 5,671 1,163
171,210 96,246

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans 26,763 32,319
Hire purchase contracts - 56,618
26,763 88,937

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 4,540 10,096

9. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Other provisions 431,000 431,000

In accordance with the compliance obligations of the business, a risk was identified and a report undertaken in the year to assess the potential financial impact of this risk on the business. The amount was calculated based on currently available facts and applicable legislation. The directors are committed to addressing this risk and plan to recalculate the risk on an annual basis and, using their management judgement, adjust accordingly.

Northumbrian Medical Supplies Limited (Registered number: 06410206)

Notes to the Financial Statements - continued
for the year ended 31 December 2024

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 December 2024 and 31 December 2023:

2024 2023
£    £   
Mrs J Tomkins
Balance outstanding at start of year 42,597 43,137
Amounts repaid (26,080 ) (540 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 16,517 42,597

R Tomkins
Balance outstanding at start of year 42,596 43,136
Amounts repaid (26,080 ) (540 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 16,516 42,596